Related to this finding, previous reports in breast cancer have shown that treatment with a PI3K inhibitor delayed tumor growth but increased indicators of DNA damage such as poly-ADP ribose (PAR) [13, 14]. This evidence concerns the gene PIK3CA and breast carcinoma.